Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

72.03
Delayed Data
As of Nov 26
 -2.02 / -2.72%
Today’s Change
56.95
Today|||52-Week Range
93.66
-6.13%
Year-to-Date

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Arrowhead Pharmaceuticals Inc have a median target of 89.00, with a high estimate of 106.00 and a low estimate of 45.00. The median estimate represents a +23.57% increase from the last price of 72.03.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Arrowhead Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.53
Sales
$38.4M
Reporting Date
Feb 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 13.82%
 
 
 
 
 
 
Growthannually 14.98%
 
 
 
 
 
 

Sales

Growthquarterly 0.41%
 
 
 
 
 
 
Growthannually 97.29%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.